Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Western Australian Institutes for Health (WAIH) is a premier medical research consortium and infrastructure management entity based in Perth, Western Australia. Established in 2008 as a strategic partnership between the University of Western Australia, the Harry Perkins Institute of Medical Research (formerly WAIMR), and the Lions Eye Institute, WAIH was created to oversee the development of world-class research facilities at the Queen Elizabeth II Medical Centre and Fiona Stanley Hospital. Supported by over $200 million in state and federal government funding, the consortium fosters innovation and clinical translation across diverse therapeutic areas, including oncology, ophthalmology, and genetic disorders. WAIH serves as a central hub for biomedical research in Western Australia, facilitating collaborations between academia, government, and industry to advance new medical therapies. Its member institutes maintain a robust pipeline of programs, ranging from pioneering gene therapies for macular degeneration to novel treatments for cancer and cardiovascular disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WA Institutes for Health.